Ornithine decarboxylase induction in transformation by H-Ras and RhoA

Cancer Research

Volumn 58, Issue 13, 1998, Pages 2748-2753

  Shantz, Lisa M ^a   Pegg, Anthony E ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; ORNITHINE DECARBOXYLASE; RAF PROTEIN; RHO FACTOR;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL TRANSFORMATION; ENZYME ACTIVITY; ENZYME INDUCTION; IMMUNOBLOTTING; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3T3 CELLS; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GTP-BINDING PROTEINS; MICE; ORNITHINE DECARBOXYLASE; PROTO-ONCOGENE PROTEINS C-RAF; RAS PROTEINS; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 0032125577     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Auvinen, M., Paasinen, A., Andersson, L. A., and Hölttä, E. Ornithine decarboxylase activity is critical for cell transformation. Nature (Lond.), 360: 355-358, 1992.
2. Moshier, J. S., Dosescu, J., Skunca, M., and Luk, G. D. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Cancer Res., 53: 2618-2622, 1993.
3. Smith, M. K., Goral, M. A., Wright, J. H., Matrisian, L. M., Morris, R. J., Klein-Szanto, A. J. P., and Gilmour, S. K. Ornithine decarboxylase overexpression leads to increased epithelial tumor invasiveness. Cancer Res., 57: 2104-2108, 1997.
4. Pegg, A. E. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res., 48: 759-774, 1988.
5. Gilmour, S. K., Robertson, F. M., Megosh, L., O'Connell, S. M., Mitchell, J., and O'Brien, T. G. Induction of ornithine decarboxylase in specific subpopulations of murine epidermal cells following multiple exposures to 12-O-tetradecanoylphorbol-13-acetate, merzerein and ethylphenylproprionate. Carcinogenesis (Lond.), 13: 51-56, 1992.
6. McCann, P. P., and Pegg, A. E. Ornithine decarboxylase as an enzyme target for therapy. Pharmacol. Ther., 54: 195-215, 1992.
7. O'Brien, T. G., Megosh, L. C., Gilliard, G., and Peralta Soler, A. Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res., 57: 2630-2637, 1997.
8. Hölttä, E., Sistonen, L., and Alitalo, K. The mechanism of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells. J. Biol. Chem., 263: 4500-4507, 1988.
9. val 12 oncogene in transformed cell clones. Exp. Cell Res., 168: 518-530, 1987.
10. Shayovitis, A., and Bachrach, U. Ornithine decarboxylase: an indicator for growth of NIH 3T3 fibroblasts and their c-Ha-ras transformants. Biochim. Biophys. Acta, 1267: 107-114, 1995.
11. Shantz, L. M., and Pegg, A. E. Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res., 54: 2313-2316, 1994.
12. Lazaris-Karatzas, A., Smith, M. R., Fredrickson, R. M., Jaramillo, M. L., Liu, Y., Kung, H., and Sonenberg, N. Ras mediates translation initiation factor 4E-induced malignant transformation. Genes Dev., 6: 1631-1642, 1992.
13. Shantz, L. M., Hu, R-H., and Pegg, A. E. Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translation initiation factor eIF-4E. Cancer Res., 56: 3265-3269, 1996.
14. Shantz, L. M., Coleman, C. S., and Pegg, A. E. Expression of an ornithine decarboxylase dominant-negative mutant reverses eukaryotic initiation factor 4E-induced cell transformation. Cancer Res., 56: 5136-5140, 1996.
15. Lowry, D. R., and Willumsen, B. M. Function and regulation of Ras. Annu. Rev. Biochem., 62: 851-891, 1993.
16. Khosravi-Far, R., and Der, C. J. The Ras signal transduction pathway. Cancer Metastasis Rev., 13: 67-89, 1994.
17. Avruch, J., Zhang, X-F., and Kyriakis, J. M. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem. Sci., 19: 279-283, 1994.
18. Ridley, A. J., and Hall, A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell, 70: 389-399, 1992.
19. Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., and Hall, A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell, 70: 401-410, 1992.
20. Prendergast, G. C., and Gibbs, J. B. Pathways of Ras function: connections to the actin cytoskeleton. Adv. Cancer Res., 62: 19-64, 1993.
21. Coleman, C. S., Stanley, B. A., and Pegg, A. E. Effect of mutations at active site residues on the activity of ornithine decarboxylase and its inhibition by active site-directed irreversible inhibitors. J. Biol. Chem., 268: 24572-24579, 1994.
22. Coleman, C. S., Stanley, B. A., Viswanath, R., and Pegg, A. E. Rapid exchange of subunits of mammalian ornithine decarboxylase. J. Biol. Chem., 269: 3155-3158, 1994.
23. Khosravi-Far, R., Solski, P. A., Clark, G. J., Kinch, M. S., and Der, C. J. Activation of Rac1, RhoA and mitogen-activated protein kinases is required for Ras transformation. Mol. Cell. Biol., 15: 6443-6453, 1995.
24. Prendergast, G. C., Khosravi-Far, R., Solski, P. A., Kurzawa, H., Lebowitz, P. F., and Der, C. J. Critical role of Rho in cell transformation by oncogenic Ras. Oncogene, 10: 2289-2296, 1995.
25. Qiu, R-G., Chen, J., Kirn, D., McCormick, F., and Symons, M. An essential role for Rac in Ras transformation. Nature (Lond.), 374: 457-459, 1995.
26. Lebowitz, P. F., Du, W., and Prendergast, G. C. Prenylation of RhoB is required for its cell transforming function but not its ability to activate serum response element-dependent transcription. J. Biol. Chem., 272: 16093-16095, 1997.
27. Khosravi-Far, R., White, M. A., Westwick, J. K., Solski, P. A., Chrzanowska-Wodnicka, M., Van Aelst, L., Wigler, M. H., and Der, C. J. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol. Cell. Biol., 16: 3923-3933, 1996.
28. White, M. A., Nicolette, C., Minden, A., Polverino, A., Van Aelst, L., Karin, M., and Wigler, M. H. Multiple Ras functions can contribute to mammalian cell transformation. Cell, 80: 533-541, 1995.
29. Perona, R., Esteve, P., Jiménez, B., Ballestero, R. P., Ramón y Cajal, S., and Lacal, J. C. Tumorigenic activity of rho genes from Aplysia californica. Oncogene, 8: 1285-1292, 1993.
30. Coso, O. A., Chiariello, M., Yu, J-C., Teramoto, H., Crespo, P., Xu, N., Miki, T., and Gutkind, J. S. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of JNK/SAPK signaling pathway. Cell, 81: 1137-1146, 1995.
31. Minden, A., Lin, A., Claret, F. X., Abo, A., and Karin, M. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell, 81: 1147-1157, 1995.
32. Qiu, R-G., Chen, J., McCormick, F., and Symons, M. A role for Rho in Ras transformation. Proc. Natl. Acad. Sci. USA, 92: 11781-11785, 1995.
33. v-src: delineation of molecular events relevant for the transformed phenotype. J. Cell Biol., 122: 903-914, 1993.
34. Paasinen-Sohns, A., and Hölttä, E. Cells transformed by ODC, c-Ha-ras and v-src exhibit MAP kinase/ERK-independent constitutive phosphorylation of Sos, Raf and c-Jun activation domain, and reduced PDGF receptor expression. Oncogene, 15: 1953-1966, 1997.
35. Hill, C. S., Wynne, J., and Treisman, R. The Rho family of GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell, 81: 1159-1170, 1995.
36. Chihara, K., Amano, M., Nakamura, N., Yano, T., Shibata, M., Tokui, T., Ichikawa, H., Ikebe, R., Ikebe, M., and Kaibuchi, K. Cytoskeletal rearrangements and transcriptional activation of c-fos serum response element by Rho-kinase. J. Biol. Chem., 272: 25121-25127, 1997.
37. Sahai, S. E., Alberts, A. S., and Treisman, R. RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation. EMBO J., 17: 1350-1361, 1998.
38. Perona, R., Montaner, M., Saniger, L., Sanchez-Perez, I., Bravo, R., and Lacal, J. C. Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev., 11: 463-475, 1997.
39. Manni, A., Wechter, R., Gilmour, S., Verderame, M. F., Mauger, D., and Demers, L. M. Ornithine decarboxylase over-expression stimulates mitogen-activated protein kinase and anchorage-independent growth of human breast epithelial cells. Int. J. Cancer, 70: 175-182, 1997.
40. Kubota, S., Kiyosawa, H., Nomura, Y., Yamada, T., and Seyama, Y. Ornithine decarboxylase overexpression in mouse 10T1/2 fibroblasts: cellular transformation and invasion. J. Natl. Cancer Inst., 89: 567-571, 1997.
41. Westwick, J. K., Cox, A. D., Der, C. J., Cobb, M. H., Hibi, M., Karin, M., and Brenner, D. A. Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular-signal regulated kinases. Proc. Natl. Acad. Sci. USA, 91: 6030-6034, 1994.
42. CAS. Mol. Cell. Biol., 15: 6513-6525, 1995.